RE:RE:I bought more!Ellesse wrote: Cantor Fitzgerald downgraded shares of CRH Medical Corp from a buy rating to a neutral rating and decreased their price target for the company from $10.00 to $3.00 in a research note on Friday, September 15st.
that was on August 31st actually - Cantor's analyst was about a month late in finally dropping his target after the CMS news. he dropped F2018E Revenues from $144MM to $94MM, which is pretty drastic and was probably done so they are closer in line with the Street's consensus.
note that's a $3 USD price target, too.
here's the full analyst report which was previously posted by stockmaster:
https://tinyurl.com/yd95n2rx